Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
在HIV阴性女性中皮下注射CAP256V2LS和VRC07-523LS的长期安全性和耐受性:随机、安慰剂对照、双盲、2期CAPRISA 012C试验的研究方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-076843
Mahomed, Sharana; Garrett, Nigel; Potloane, Disebo; Sikazwe, Izukanji T; Capparelli, Edmund; Harkoo, Ishana; Gengiah, Tanuja Narayansamy; Zuma, Nonhlanhla Yende; Osman, Farzana; Mansoor, Leila; Archary, Derseree; Myeni, Nqobile; Radebe, Precious; Samsunder, Natasha; Doria-Rose, Nicole; Carlton, Kevin; Gama, Lucio; Koup, Richard A; Narpala, Sandeep; Serebryannyy, Leonid; Moore, Penny; Williamson, Carolyn; Pozzetto, Bruno; Hankins, Catherine; Morris, Lynn; Karim, Quarraisha Abdool; Abdool Karim, Salim